Deutsche Bank
TTPH

Deutsche Bank’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Deutsche Bank’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,153
Closed -$22K – 5227
2019
Q3 		$22K Sell
4,153
-2,888
-41% -$19.2K ﹤0.01% 4295
2019
Q2 		$66K Sell
7,041
-2,320
-25% -$42.7K ﹤0.01% 4395
2019
Q1 		$250K Sell
9,361
-42,661
-82% -$1.09M ﹤0.01% 3876
2018
Q4 		$1.17M Buy
52,022
+45,686
+721% +$1.79M ﹤0.01% 2773
2018
Q3 		$349K Sell
6,336
-523
-8% -$33.4K ﹤0.01% 3970
2018
Q2 		$490K Sell
6,859
-16,036
-70% -$1.13M ﹤0.01% 3859
2018
Q1 		$1.41M Buy
22,895
+11,824
+107% +$1.04M ﹤0.01% 3107
2017
Q4 		$1.39M Buy
11,071
+6,950
+169% +$890K ﹤0.01% 2977
2017
Q3 		$562K Sell
4,121
-2,200
-35% -$294K ﹤0.01% 3370
2017
Q2 		$900K Sell
6,321
-2,677
-30% -$414K ﹤0.01% 3104
2017
Q1 		$1.65M Sell
8,998
-3,936
-30% -$441K ﹤0.01% 2370
2016
Q4 		$1.04M Sell
12,934
-4,488
-26% -$355K ﹤0.01% 2663
2016
Q3 		$1.33M Buy
17,422
+1,619
+10% +$130K ﹤0.01% 2634
2016
Q2 		$1.36M Sell
15,803
-620
-4% -$56.8K ﹤0.01% 2667
2016
Q1 		$1.52M Buy
16,423
+10,493
+177% +$1.05M ﹤0.01% 2550
2015
Q4 		$1.19M Buy
5,930
+2,940
+98% +$587K ﹤0.01% 2766
2015
Q3 		$444K Buy
2,990
+854
+40% +$627K ﹤0.01% 3426
2015
Q2 		$2.02M Sell
2,136
-702
-25% -$574K ﹤0.01% 2446
2015
Q1 		$2.08M Buy
2,838
+2,423
+584% +$1.82M ﹤0.01% 2405
2014
Q4 		$329K Sell
415
-3,294
-89% -$1.77M ﹤0.01% 3985
2014
Q3 		$1.48M Sell
3,709
-561
-13% -$150K ﹤0.01% 2730
2014
Q2 		$1.15M Buy
4,270
+3,977
+1,357% +$853K ﹤0.01% 2843
2014
Q1 		$63K Buy
293
+153
+109% +$42.6K ﹤0.01% 4445
2013
Q4 		$37K Sell
140
-546
-80% -$130K ﹤0.01% 4480
2013
Q3 		$155K Buy
686
+342
+99% +$59.8K ﹤0.01% 4244
2013
Q2 		$48K Buy
+344
New +$54.5K ﹤0.01% 4531

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deutsche Bank's TTPH Position: Q4 2019 in Review

Deutsche Bank sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2019, closing a stake of 4,153 shares — an estimated $22K sold.

Deutsche Bank first reported a position in TTPH in Q2 2013 and held it in 26 quarters. The position peaked at $2.08M in Q1 2015. 23 funds tracked by Wall St. Rank hold TTPH as of Q4 2019.

  • Deutsche Bank reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • Deutsche Bank sold 4,153 Tetraphase Pharmaceuticals, Inc. shares in Q4 2019, an estimated $22K.
  • Deutsche Bank first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
  • Deutsche Bank's Tetraphase Pharmaceuticals, Inc. position peaked at $2.08M in Q1 2015.
  • 23 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.